Ephedrine Alkaloid/Caffeine Combos Risk Unproven - Metabolife
This article was originally published in The Tan Sheet
Executive Summary
FDA's proposed ban on the marketing of ephedrine alkaloid and caffeine combination products lacks substantiating data and should be withdrawn by the agency, according to supplement marketer Metabolife.